Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems
- PMID: 17716196
- DOI: 10.2217/17435889.2.1.99
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems
Abstract
This review details the recent advancements in the design of mesoporous silica nanomaterials for controlled release drug, gene and neurotransmitter delivery applications. The high surface area (>900 m2/g), tunable pore diameter (2-20 nm) and uniform mesoporous structure (hexagonal channels or cubic pores) of the mesoporous silicas offer a unique advantage for loading and releasing large quantities of biomedical agents. Recent breakthroughs in controlling the particle size and shape of these materials have greatly improved the biocompatibility and the cellular uptake efficiency. The strategy of using various removable capping moieties, such as photo- or redox-responsive organic groups, inorganic nanoparticles, dendrimers and polymers, to encapsulate guest biomolecules inside the porous matrices further enables the utilization of these surface-functionalized mesoporous silica nanomaterials for stimuli-responsive controlled release in vitro and in vivo. In addition to the reviewed studies, many new and exciting applications of these novel materials will soon be realized.
Similar articles
-
Shape matters when engineering mesoporous silica-based nanomedicines.Biomater Sci. 2016 Apr;4(4):575-91. doi: 10.1039/c5bm00589b. Epub 2016 Jan 28. Biomater Sci. 2016. PMID: 26818852
-
Nanostructured mesoporous silica matrices in nanomedicine.J Intern Med. 2010 Jan;267(1):22-43. doi: 10.1111/j.1365-2796.2009.02190.x. J Intern Med. 2010. PMID: 20059642 Review.
-
A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.J Am Chem Soc. 2003 Apr 16;125(15):4451-9. doi: 10.1021/ja028650l. J Am Chem Soc. 2003. PMID: 12683815
-
Mesoporous silica nanoparticles for intracellular controlled drug delivery.Small. 2010 Sep 20;6(18):1952-67. doi: 10.1002/smll.200901789. Small. 2010. PMID: 20690133 Review.
-
Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine.Nanomedicine (Lond). 2011 Jul;6(5):867-77. doi: 10.2217/nnm.11.82. Nanomedicine (Lond). 2011. PMID: 21793677 Review.
Cited by
-
Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.Int J Nanomedicine. 2022 Jul 14;17:3079-3096. doi: 10.2147/IJN.S363952. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35859731 Free PMC article.
-
Lipid-mediated DNA and siRNA Transfection Efficiency Depends on Peptide Headgroup.Soft Matter. 2013 May 5;9(17):10.1039/C3SM27633C. doi: 10.1039/C3SM27633C. Soft Matter. 2013. PMID: 24391676 Free PMC article.
-
Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.Antimicrob Agents Chemother. 2012 May;56(5):2535-45. doi: 10.1128/AAC.06049-11. Epub 2012 Feb 21. Antimicrob Agents Chemother. 2012. PMID: 22354311 Free PMC article.
-
Biomimetic Intrafibrillar Mineralization of Type I Collagen with Intermediate Precursors-loaded Mesoporous Carriers.Sci Rep. 2015 Jun 8;5:11199. doi: 10.1038/srep11199. Sci Rep. 2015. PMID: 26053330 Free PMC article.
-
Crystal structure and silica condensing activities of silicatein alpha-cathepsin L chimeras.Chem Commun (Camb). 2008 Apr 21;(15):1765-7. doi: 10.1039/b718264c. Epub 2008 Feb 11. Chem Commun (Camb). 2008. PMID: 18379686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources